- BioTelemetry, the primary and only real contender for iRhythm, was just acquired by tech giant Philips.
- BioTelemetry's product line will be rapidly placed on the forefront of the Philips' Connected Care Solutions business, which will vastly diminish the available market size for iRhythm.
- Still unprofitable, iRhythm appears more vulnerable than ever with shares inflated nearly 300% in the past year.
- Recent changes to reimbursement codes for iRhythm products provide limitless uncertainty to the future of the company, with a decision by CMS due by year end.
For further details see:
IRhythm Technologies Biotelemetry Acquired By Goliath Philips